Utah Medical Products, Inc.UTMDNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank29
3Y CAGR-14.2%
5Y CAGR-10.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-14.2%/yr
Annual compound
5Y CAGR
-10.4%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | -34.5% |
| 2024 | 0.00 | +25.2% |
| 2023 | 0.00 | -23.0% |
| 2022 | 0.00 | -19.3% |
| 2021 | 0.00 | +13.4% |
| 2020 | 0.00 | -12.4% |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |